Prazitam 4.5

Prazitam 4.5 Dosage/Direction for Use

piperacillin + tazobactam

Manufacturer:

Stallion Labs

Distributor:

Clearvue Pharma

Marketer:

Ambica
Full Prescribing Info
Dosage/Direction for Use
Piperacillin/Tazobactam (PRAZITAM) should be administered by intravenous infusion over 30 minutes.
Adults: The usual total daily dose of Piperacillin/Tazobactam is 3.375 g every six hours totaling 13.5 g (12.0 g Piperacillin/1.5 g Tazobactam). Initial presumptive treatment of patients with nosocomial pneumonia should start with (16.0 g Piperacillin/2.0 g Tazobactam). Treatment with aminoglycoside should be continued in patients from whom Pseudomonas aeruginosa is isolated. If Pseudomonas aeruginosa is not isolated, the aminoglycoside may be discontinued at the discretion of the treating physician.
Pediatrics: Piperacillin/Tazobactam (PRAZITAM) can be administered in pediatric patients from 2 months of age. The dosage and indications in pediatric patients with normal renal function are as follows: See Table 1.

Click on icon to see table/diagram/image

Duration of Therapy: The usual duration of Piperacillin/Tazobactam (PRAZITAM) treatment is from seven to ten days. However, the recommended duration of treatment of nosocomial pneumonia is 7 to 14 days. In all conditions, the duration of therapy should be guided by the severity of the infection and the patient's clinical and bacteriological progress.
Renal Insufficiency: In patients with renal insufficiency (creatinine clearance < mL/min), the intravenous dose of Piperacillin/Tazobactam (PRAZITAM) should be adjusted to the degree of actual renal function impairment. In patients with nosocomial pneumonia receiving concomitant aminoglycoside therapy, the aminoglycoside dosage should be adjusted according to the recommendation of the manufacturer.
The recommended daily doses of Piperacillin/Tazobactam (PRAZITAM) for patients with renal insufficiency are as follows: Adults: See Table 2.

Click on icon to see table/diagram/image

For patients on haemodialysis, the maximum dose is 2.25 g every twelve hours for all indications other than nosocomial pneumonia and 2.25 g every eight hours for nosocomial pneumonia. Since haemodialysis removes 30% to 40% of the administered dose, an additional dose of 0.75 g Piperacillin/Tazobactam (PRAZITAM) should be administered following each dialysis period on haemodialysis days. No additional dosage of Piperacillin/Tazobactam (PRAZITAM) is necessary for CAPD patients.
Pediatrics: There are no dosage recommendation for Piperacillin/Tazobactam in pediatric patients with impaired renal function.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in